SG177535A1 - Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof - Google Patents

Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof Download PDF

Info

Publication number
SG177535A1
SG177535A1 SG2012000964A SG2012000964A SG177535A1 SG 177535 A1 SG177535 A1 SG 177535A1 SG 2012000964 A SG2012000964 A SG 2012000964A SG 2012000964 A SG2012000964 A SG 2012000964A SG 177535 A1 SG177535 A1 SG 177535A1
Authority
SG
Singapore
Prior art keywords
cyclopropane
dimethyl
difluoro
fluoro
dioxolan
Prior art date
Application number
SG2012000964A
Other languages
English (en)
Inventor
Andreas Maderna
Jean-Michel Vernier
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG177535(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of SG177535A1 publication Critical patent/SG177535A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
SG2012000964A 2009-07-24 2010-07-10 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof SG177535A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24
PCT/EP2010/004222 WO2011009541A1 (en) 2009-07-24 2010-07-10 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Publications (1)

Publication Number Publication Date
SG177535A1 true SG177535A1 (en) 2012-03-29

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2012000964A SG177535A1 (en) 2009-07-24 2010-07-10 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Country Status (31)

Country Link
US (3) US8513443B2 (enExample)
EP (1) EP2462111B1 (enExample)
JP (1) JP5776115B2 (enExample)
KR (1) KR101763437B1 (enExample)
CN (2) CN103848808B (enExample)
AR (1) AR079183A1 (enExample)
AU (1) AU2010275780B2 (enExample)
BR (1) BR112012001592A2 (enExample)
CA (2) CA2768788C (enExample)
CL (1) CL2012000192A1 (enExample)
CO (1) CO6491075A2 (enExample)
CR (1) CR20120044A (enExample)
CU (1) CU24113B1 (enExample)
DO (1) DOP2012000017A (enExample)
EA (1) EA023623B1 (enExample)
EC (1) ECSP12011621A (enExample)
GT (1) GT201200017A (enExample)
HN (1) HN2012000142A (enExample)
IL (1) IL217312A (enExample)
IN (1) IN2012DN00696A (enExample)
MA (1) MA33452B1 (enExample)
MX (2) MX2012001063A (enExample)
MY (1) MY160421A (enExample)
NZ (1) NZ597738A (enExample)
PE (1) PE20120573A1 (enExample)
PH (1) PH12014500158B1 (enExample)
SG (1) SG177535A1 (enExample)
TN (1) TN2012000027A1 (enExample)
TW (1) TWI524890B (enExample)
UY (1) UY32800A (enExample)
WO (1) WO2011009541A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備
UA113850C2 (xx) * 2011-05-27 2017-03-27 Хіральний синтез n-{3,4-дифтор-2-$(2-фтор-4-йодфеніл)аміно]-6-метоксифеніл}-1-$2,3-дигідроксипропіл]циклопропансульфонамідів
EP2796455A4 (en) * 2011-12-19 2015-08-19 Sumitomo Chemical Co PROCESS FOR THE PREPARATION OF SULPHONATE
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495118B (zh) * 2005-07-21 2012-09-05 阿迪亚生命科学公司 Mek的n-(芳基氨基)磺酰胺抑制剂
US8101799B2 (en) 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
AU2007237901B2 (en) * 2006-04-18 2012-07-05 Ardea Biosciences, Inc. Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
CA2694646C (en) * 2007-07-30 2017-09-05 Ardea Biosciences, Inc. Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
CN102131771A (zh) * 2008-04-14 2011-07-20 阿迪生物科学公司 组合物及其制备和使用方法
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備

Also Published As

Publication number Publication date
EA201200175A1 (ru) 2012-12-28
CA2768788A1 (en) 2011-01-27
CO6491075A2 (es) 2012-07-31
MA33452B1 (fr) 2012-07-03
KR101763437B1 (ko) 2017-07-31
CL2012000192A1 (es) 2012-10-05
UY32800A (es) 2011-01-31
HN2012000142A (es) 2015-06-08
ECSP12011621A (es) 2012-02-29
CN102471246B (zh) 2015-08-26
IL217312A (en) 2017-02-28
JP5776115B2 (ja) 2015-09-09
US9296686B2 (en) 2016-03-29
TW201113017A (en) 2011-04-16
AU2010275780B2 (en) 2015-10-22
KR20120032536A (ko) 2012-04-05
PE20120573A1 (es) 2012-05-17
BR112012001592A2 (pt) 2016-03-08
PH12014500158A1 (en) 2015-09-07
MX2012001063A (es) 2012-03-26
US8513443B2 (en) 2013-08-20
AR079183A1 (es) 2012-01-04
CU24113B1 (es) 2015-08-27
IL217312A0 (en) 2012-02-29
AU2010275780A1 (en) 2012-02-02
CU20120014A7 (es) 2012-06-21
US20150274651A1 (en) 2015-10-01
US20130261320A1 (en) 2013-10-03
HK1198364A1 (zh) 2015-04-10
JP2013500242A (ja) 2013-01-07
CR20120044A (es) 2012-03-12
TN2012000027A1 (en) 2013-09-19
US8884058B2 (en) 2014-11-11
EA023623B1 (ru) 2016-06-30
CN103848808A (zh) 2014-06-11
CA2768788C (en) 2018-01-09
NZ597738A (en) 2014-03-28
CA2990097A1 (en) 2011-01-27
HK1171218A1 (en) 2013-03-22
DOP2012000017A (es) 2012-05-15
PH12014500158B1 (en) 2015-09-07
IN2012DN00696A (enExample) 2015-06-19
WO2011009541A1 (en) 2011-01-27
CN102471246A (zh) 2012-05-23
GT201200017A (es) 2013-12-19
MY160421A (en) 2017-03-15
US20120178946A1 (en) 2012-07-12
CN103848808B (zh) 2016-02-10
TWI524890B (zh) 2016-03-11
EP2462111B1 (en) 2016-03-30
EP2462111A1 (en) 2012-06-13
MX344965B (es) 2017-01-12

Similar Documents

Publication Publication Date Title
Bravo et al. New fluorinated chiral synthons
EP1140788B1 (en) Method for the preparation of aryl ethers
AU2010275780B2 (en) Preparation of (R)- and (S)-N-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof
Tap et al. Asymmetric synthesis of a highly functionalized enantioenriched system close to thapsigargin framework
AU2012264884B2 (en) Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides
HK1171218B (en) Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof
HK1198364B (en) Midbody of mek enzyme inhibitor
KR102300311B1 (ko) 타칼시톨의 제조방법 및 그를 위한 중간체
Nosyreva et al. Cyanoacetylene and Its Derivatives: XXVIII. Reactions of 2-Mercaptobenzothiazole with Nitriles of αα, ββ-Acetylene γγ-Hydroxyacids and with 3-Phenyl-2-propynonitrile
Merino et al. Nucleophilic additions of chiral non-racemic enolates to N-benzyl-C-(alkoxymethyl) nitrones